Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Arthur Website

Diane C. Arthur, M.D.

Selected Publications

1)  Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, Daub JR, Spalding CD, Claypool RJ, Giri NK, Alter BP, Mace EM, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM.
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Blood. 123: 809-21, 2014.
[Journal]
2)  Shaffer BC, Modric M, Stetler-Stevenson M, Arthur DC, Steinberg SM, Liewehr DJ, Fowler DH, Gale RP, Bishop MR, Pavletic SZ.
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.
Exp. Hematol. 41: 772-8, 2013.
[Journal]
3)  Stetler-Stevenson M, DiGiuseppe J, Arthur D.
Kottke-Marchant K, Davis B, eds.
Myelodysplastic Disorders. In: Laboratory Hematology Practice.
West Sussex: Wiley-Blackwell; 2012. p. 331-344 [Book Chapter]
4)  Degheidy HA, Gadalla SM, Farooqui MZ, Abbasi F, Arthur DC, Bauer SR, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.
Bcl-2 level as a biomarker for 13q14 deletion in CLL.
Cytometry B Clin Cytom. 84: 237-47, 2012.
[Journal]
5)  Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.
Combined normal donor and CLL: Single tube ZAP-70 analysis.
Cytometry B Clin Cytom. 82: 67-77, 2012.
[Journal]
6)  Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS.
Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: Diagnostic and therapeutic challenges.
Am. J. Hematol. 87: 916-22, 2012.
[Journal]
7)  Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wiestner A, Stetler-Stevenson MA, Marti GE.
Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation.
Cytometry B Clin. Cytom. 80: 309-17, 2011.
[Journal]
8)  Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.
Methodological comparison of two anti-ZAP-70 antibodies.
Cytometry B Clin. Cytom. 80: 300-8, 2011.
[Journal]
9)  Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM.
Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.
Haematologica. 96: 1221-5, 2011.
[Journal]
10)  Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A.
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Blood. 117: 563-74, 2011.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 2/25/2014.